Nanobacterie Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 2

Nanobacterie General Information

Description

Developer of a magnetic nanotech-based treatment therapy designed to treat cancerous tumors. The company's therapy uses nanoparticles containing iron oxide, which are introduced into solid tumors and then subjected to an alternating magnetic field, enabling doctors to dissolve tumor tissue through this therapy without any complications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Corporate Office
  • Building 201, University Paris-Sud
  • 91405 Orsay
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanobacterie Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nanobacterie‘s full profile, request access.

Request a free trial

Nanobacterie Patents

Nanobacterie Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3142904-A1 Nanoparticles arranged in chains in an isotonic composition after reconstitution Pending 07-Dec-2022 0000000000
EP-4371574-A1 Iron oxide nanoparticles comprising two centers of activities or free radical capture/production for an enhanced activity Pending 15-Nov-2022 00000000000
EP-4371575-A1 Combining spatial and temporal sequences of irradiation using a specific nano-system for an improved treatment of diseases such as cancer Pending 15-Nov-2022 00000000000
CA-3220038-A1 A method to enable nanoparticles stored with a specific type of assembly to maintain this type of assembly upon reconstitution Pending 15-Nov-2022 00000000000
US-20240156745-A1 Iron oxide nanoparticles comprising two centers of activities or free radical capture/production for an enhanced activity and combining spatial and temporal sequences of irradiation using the nanoparticles for an improved treatment of diseases Pending 15-Nov-2022 A61K9/5176
To view Nanobacterie’s complete patent history, request access »

Nanobacterie Executive Team (2)

Name Title Board Seat Contact Info
Edouard Alphandery Co-Founder, Chief Executive Officer, Scientific Director, President, Scientific Advisor and Chairman of the supervisory board
Laurence Rivain Co-Founder, Chairman of the Supervisory Board and Board Member
To view Nanobacterie’s complete executive team members history, request access »

Nanobacterie Board Members (1)

Name Representing Role Since
00000000 000000 Nanobacterie Co-Founder, Chairman of the Supervisory Board and Board Member 000 0000
To view Nanobacterie’s complete board members history, request access »

Nanobacterie Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanobacterie Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nanobacterie‘s full profile, request access.

Request a free trial

Nanobacterie FAQs

  • When was Nanobacterie founded?

    Nanobacterie was founded in 2008.

  • Who is the founder of Nanobacterie?

    Edouard Alphandery and Laurence Rivain are the founders of Nanobacterie.

  • Who is the CEO of Nanobacterie?

    Edouard Alphandery is the CEO of Nanobacterie.

  • Where is Nanobacterie headquartered?

    Nanobacterie is headquartered in Orsay, France.

  • What is the size of Nanobacterie?

    Nanobacterie has 5 total employees.

  • What industry is Nanobacterie in?

    Nanobacterie’s primary industry is Biotechnology.

  • Is Nanobacterie a private or public company?

    Nanobacterie is a Private company.

  • What is the current valuation of Nanobacterie?

    The current valuation of Nanobacterie is 0000.

  • What is Nanobacterie’s current revenue?

    The current revenue for Nanobacterie is 000000.

  • How much funding has Nanobacterie raised over time?

    Nanobacterie has raised $3.75M.

  • Who are Nanobacterie’s investors?

    EP Equity Investment and Agoranov have invested in Nanobacterie.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »